InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Participation in Upcoming Biotech Conference
180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, will be participating in A.G.P.’s Virtual Biotech Conference. The conference is scheduled for Nov. 30–Dec. 1, 2022. According to the announcement, ATNF president and CEO Dr. James Woody will present during the event. His presentation will include a business and…